Lucid Diagnostics Inc. (LUCD) Earnings Call Analysis

NASDAQ · Healthcare · Medical Devices

Earnings Reports

• Lucid Diagnostics (LUCD) Q1 2026: $16.8M Equity Raise Extends Runway as Medicare Decision Looms
  May 15, 2026
• Lucid Diagnostics (LUCD) Q4 2025: Test Volume Jumps 29% as VA and Medicare Access Catalysts Approach
  March 26, 2026
• Lucid Diagnostics (LUCD) Q3 2025: $27M Capital Raise Extends Runway as Medicare Coverage Decision Nears
  November 12, 2025
• Lucid Diagnostics (LUCD) Q2 2025: Commercial Revenue Jumps 40% as Medicare Coverage Milestone Nears
  August 13, 2025

Browse all companies